303 related articles for article (PubMed ID: 310886)
21. Antibody to extractable nuclear antigen in the rheumatic diseases.
McCain GA; Bell DA; Chodirker WB; Komar RR
J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
[TBL] [Abstract][Full Text] [Related]
22. A Rasch analysis for classification of systemic lupus erythematosus and mixed connective tissue disease.
Perkins K; Hoffman RW; Bezruczko N
J Appl Meas; 2008; 9(2):136-50. PubMed ID: 18480510
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
[TBL] [Abstract][Full Text] [Related]
24. SLE or MCTD and the snurp in the splicing.
Whittingham S
J Rheumatol; 1990 Oct; 17(10):1260-2. PubMed ID: 1701487
[No Abstract] [Full Text] [Related]
25. [Nephropathy in patients with mixed connective tissue disease].
Yoshida A; Morozumi K; Takeda A; Koyama K
Ryumachi; 1994 Dec; 34(6):976-80. PubMed ID: 7863388
[TBL] [Abstract][Full Text] [Related]
26. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
[TBL] [Abstract][Full Text] [Related]
28. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
[TBL] [Abstract][Full Text] [Related]
29. [The Sharp syndrome (mixed connective tissue diseases) (author's transl)].
Seelig HP
Immun Infekt; 1981 Nov; 9(6):223-31. PubMed ID: 6978280
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
31. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
32. Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease.
Lage LV; de Carvalho JF; Caleiro MT; Yoshinari NH; da Mota LM; Khamashta MA; Cossermelli W
Isr Med Assoc J; 2012 Feb; 14(2):84-7. PubMed ID: 22693786
[TBL] [Abstract][Full Text] [Related]
33. Conversion of discoid lupus erythematosus to mixed connective tissue disease.
Gilliam JN; Prystowsky SD
J Rheumatol; 1977; 4(2):165-9. PubMed ID: 881692
[TBL] [Abstract][Full Text] [Related]
34. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
35. [Development of "mixed connective tissue disease" (MCTD) from discoid lupus erythematosus].
Bauer R; Schultz-Ehrenburg U; Orfanos CE
Hautarzt; 1981 Jan; 32(1):23-7. PubMed ID: 6971860
[TBL] [Abstract][Full Text] [Related]
36. Circulating autoantibodies to IgD in rheumatic diseases.
Pope RM; Keightley R; McDuffy S
J Immunol; 1982 Apr; 128(4):1860-3. PubMed ID: 6977573
[TBL] [Abstract][Full Text] [Related]
37. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
39. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
[TBL] [Abstract][Full Text] [Related]
40. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
